Switching of prescription drugs to over-the-counter status. Is it a good thing for the elderly?

Drugs and Aging

Volumn 22, Issue 5, 2005, Pages 361-370

  Francis, Sally Anne ^a   Barnett, Nina ^b   Denham, Michael ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; CELECOXIB; CHLORPHENIRAMINE; CIMETIDINE; CYCLOOXYGENASE 2 INHIBITOR; DECONGESTIVE AGENT; DIPHENHYDRAMINE; DOXYLAMINE; FAMOTIDINE; GASTROINTESTINAL AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; KETOPROFEN; LAXATIVE; MEVINOLIN; NAPROXEN; NIZATIDINE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OXYMETAZOLINE; PARACETAMOL; RANITIDINE; SEDATIVE AGENT; SIMVASTATIN; XYLOMETAZOLINE;

ANTICHOLINERGIC EFFECT; CLINICAL PRACTICE; CONFUSION; CONGESTIVE HEART FAILURE; COST CONTROL; DATA BASE; DIGESTIVE SYSTEM INJURY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG COST; DRUG EFFICACY; DRUG MISUSE; DRUG PREFERENCE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG USE; DRUG UTILIZATION; DYSPEPSIA; ELDERLY CARE; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HUMAN; INSOMNIA; LIVER TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SELF EVALUATION; SEX DIFFERENCE;

AGED; CONSUMER PRODUCT SAFETY; DRUGS, NON-PRESCRIPTION; ETHNIC GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL SERVICES; RISK ASSESSMENT; SELF MEDICATION;

EID: 22344443075     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200522050-00001     Document Type: Review

References (69)

1. Lowell M. Consumer trends in self diagnosis, home testing and over the counter medication: implications for the registered nurse. Kans Nurse 1995; 70 (5): 1-2
2. Barber N. Drugs: from prescription to pharmacy only. BMJ 1993; 307: 640
3. Food and Drug Administration/Centre for Drug Evaluation and Research. Over-the counter drug products public hearing 2000 [online]. Available from URL: http://www.fda.gov/cder/meet-ing/otcga-6000.htm [Accessed 2004 Mar 10]
4. Minghetti P, Casiraghi A, Cilurzo F, et al. The situation of OTC drugs in Italy compared to the other EU states. Pharmacol Res 2000; 42: 25-31
5. Parmley WW. OTC or not OTC - that is the question. J Am Coll Cardiol 2000; 36 (4): 1426-7
6. Schulke DG. American Pharmaceutical Association review of literature on prescription to over-the-counter drug switches. Clin Ther 1998; 20 Suppl. C: C124-33
7. Amoako EP, Richardson-Campbell L, Kennedy-Malone L. Self-medication with over-the-counter drugs among elderly adults. J Gerontol Nurs 2003; 29 (8): 10-5
8. Pharand C, Ackman ML, Jackevicius CA, et al. Use of OTC and herbal products in patients with cardiovascular disease. Ann Pharmacother 2003; 37 (6): 899-904
9. Thomas J, Straus WL, Bloom BS. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms. Am J Gastroenterol 2002; 97 (9): 2215-9
10. Sleath B, Rubin RH, Campbell W, et al. Physician-patient communication about over-the-counter medications. Soc Sci Med 2001; 53 (3): 357-69
11. Ackman ML, Campbell JB, Buzak KA, et al. Use of nonpre-scription medications by patients with congestive heart failure. Ann Pharmacother 1999; 33 (6): 674-9
12. Roumie CL, Griffin MR. Over-the-counter analgesics in older adults: a call for improved labelling and consumer education. Drugs Aging 2004; 21 (8): 485-98
13. Stoehr GP, Ganguli M, Seaberg EC, et al. Over-the-counter medication use in an older rural community: the MoVIES Project. J Am Geriatr Soc 1997; 45 (2): 158-65
14. Conn VS. Self-management of over-the-counter medications by older adults. Public Health Nurs 1992; 9 (1): 29-36
15. Salom IL, Davis K. Prescribing for older patients: how to avoid toxic drug-reactions. Geriatrics 1995; 50: 37-43
16. Fillenbaum GG, Horner RD, Hanlon JT, et al. Factors predicting change in prescription and nonprescription drug use in a community-residing black and white elderly population. J Clin Epidemiol 1996; 49 (5): 587-93
17. Johnson RE, Ried LD. OTC drug use in an HMO: comparing the elderly and younger adults. J Aging Health 1996; 8 (1): 114-35
18. Chrischilles EA, Lemke JH, Wallace RB, et al. Prevalence and characteristics of multiple analgesic drug use in an elderly group study. J Am Geriatr Soc 1990; 38 (9): 979-84
19. Conn VS. Older adults: factors that predict the use of over-the-counter medication. J Adv Nurs 1991; 16 (10): 1190-6
20. Hanlon JT, Fillenbaum GG, Studenski SA, et al. Factors associated with suboptimal analgesic use in community dwelling elderly. Ann Pharmacother 1996; 30 (7-8): 739-44
21. Walop W, Amos S, Dalziel W, et al. Prescription and nonprescription drug use among at-risk community-dwelling seniors in Ottawa-Carleton. Can J Clin Pharmacol 1999; 6 (2): 93-100
22. Hanlon JT, Fillenbaum GG, Ruby CM, et al. Epidemiology of over-the-counter drug use in community dwelling elderly: United States perspective. Drugs Aging 2001; 18 (2): 123-31
23. Sihvo S, Klaukka T, Martikainen J, et al. Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population. Eur J Clin Pharmacol 2000; 56 (6-7): 495-9
24. Espino DV, Lichtenstein MJ, Hazuda HP, et al. Correlates of prescription and over-the-counter medication usage among older Mexican Americans: the Hispanic EPESE study. Established Population for the Epidemiologic Study of the Elderly. J Am Geriatr Soc 1998; 46 (10): 1228-34
25. Westerlund LOT, Marklund BRG, Handl WHA, et al. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother 2001; 35: 1343-9
26. McElnay JC, McCallion R. Non-prescription drug use by elderly patients. Int J Pharm Pract 1996; 4: 12-8
27. Mason P. Has reclassification of GI drugs changed the treatment of disease? Pharm J 1996; 257: 731-2
28. Erwin J, Britten N, Jones R. General practitioners' views on the over-the-counter availability of H2-antagonists. Br J Gen Pract 1997; 47 (415): 99-102
29. Brass EP. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 2001; 345: 810-5
30. Stuart B, Grana J. Are prescribed and over-the-counter medicines economic substitutes? A study of the effects of health insurance on medicine choices by the elderly. Med Care 1995; 33 (5): 487-501
31. Byrns PJ. Prescription to over-the-counter switches: the physi-cian perspective. Clin Ther 1998; 20 Suppl. C: C118-23
32. Batty GM, Oborne CA, Swift CG, et al. The use of over-the-counter medication by elderly medical in-patients. Postgrad Med J 1997; 73 (865): 720-2
33. Busto UE, Sproule BA, Knight K, et al. Use of prescription and nonprescription hypnotics in a Canadian elderly population. Can J Clin Pharmacol 2001; 8 (4): 213-21
34. Barnett NL, Denham MJ, Francis SA. Over-the-counter medicines and the elderly. J R Coll Physicians Lond 2000; (5): 445-6
35. Honig PK, Gillespie BK. Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs. Clin Pharmacokinet 1988; 35 (3): 167-71
36. Royal College of Physicians. Medication for older people. 2nd ed. London: RCP, 1997
37. Department of Health. National service framework for older people. London: The Stationery Office, 2001
38. Bissell P, Ward PR, Noyce PR. Mapping the contours of risk: consumer perceptions of non-prescription medicines. J Soc Adm Pharm 2000; 17: 136-42
39. Rumelt MB. Blindness from misuse of over-the-counter eye medications. Ann Ophthalmol 1988; 20 (1): 26-7, 30
40. Ferris DG, Nyirjesy P, Sobel JD, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002; 99 (3): 419-25
41. Benrimoj SI, Langford JH, Bowden MG, et al. Switching drug availability from prescription only to over-the-counter status: are elderly patients at increased risk? Drugs Aging 1995; 7 (4): 255-65
42. Marklund B, Lemne C, Andersson I-L, et al. Short- and longterm behavioural and medical effects of the OTC introduction of the first H2-blocker in Sweden. J Soc Adm Pharm 2001; 18 (1): 35-40
43. Shaw MJ, Fendrick AM, Kane RL, et al. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists. Am J Gastroenterol 2001; 96 (3): 673-6
44. Cebollero-Santamaria F, Smith J, Gioe S, et al. Selective outpatient management of upper gastrointestinal bleeding in the elderly. Am J Gastroenterol 1999; 94 (5): 1242-7
45. Lanza FL, Codispoti JR, Nelson EB. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen. Am J Gastroenterol 1998; 93 (7): 1051-4
46. Doyle G, Furey S, Berlin R, et al. Gastrointestinal safety and tolerance of ibuprofen at maximum over-the-counter dose. Aliment Pharmacol Ther 1999; 13 (7): 897-906
47. Blot WJ, McLaughlin JK. Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding. J Epidemiol Biostat 2000; 5 (2): 137-42
48. Motola G, Russo F, Mazzeo F, et al. Over-the-counter oral nonsteroidal anti-inflammatory drugs: a pharmacoepidemio logic study in southern Italy. Adv Ther 2001; 18 (5): 216-22
49. Scheiman JM, Cryer B, Kimmey MB, et al. A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury. Clin Gastroenterol Hepatol 2004; 2 (4): 290-5
50. Lasagna L. Over-the-counter hypnotics and chronic insomnia in the elderly. J Clin Psychopharmacol 1995; 15 (6): 383-6
51. Johnson JE. Insomnia, alcohol, and over-the-counter drug use in old-old urban women. J Community Health Nurs 1997; 14 (3): 181-8
52. Weintraub M. Guidance for industry: over-the-counter treatment of hypercholesterolaemia. 1998 [online]. Available from URL: http://www.fda.gov/ cder/guidance/index.htm [Accessed 2004 Mar 10]
53. Dyer O. FDA rejects sale of over the counter statins. BMJ 2005; 330: 164
54. Bayliss E, Rutter P. General practitioners' views on recent and proposed medicine switches from POM to P. Pharm J 2004; 273: 819-21
55. Dyer O. Consumers' Association voices concern at over the counter statins. BMJ 2004; 329: 310
56. OTC statins: a bad decision for public health. Lancet 2004; 3563: 1659
57. Bradley C, Blenkinsopp A. Over the counter drugs: the future for self-medication. BMJ 1996; 312: 835-7
58. Stoller EP. Prescribed and over-the-counter medicine use by the ambulatory elderly. Med Care 1988; 26 (12): 1149-57
59. Holden MD. Over-the-counter medications: do you know what your patients are taking? Postgrad Med 1992; 91 (8): 191-4, 199-200
60. Sansgiry SS, Cady PS. How the elderly and young adults differ in the decision making process of nonprescription medication purchases. Health Mark Q 1996; 14 (1): 3-21
61. Isacson D, Bingefors C. On Rx switches and access to over-the-counter drugs in Sweden. J Soc Adm Pharm 1999; 16 (1): 13-25
62. Sansgiry SS, Cady PS, Patil S. Readability of over-the-counter medication labels. J Am Pharm Assoc 1997; NS37: 522-8
63. Johnson MM, Drungle SC. Purchasing over-the-counter medi-cations: the influence of age and familiarity. Exp Aging Res 2000; 26 (3): 245-61
64. Watanabe RK, Gilbreath K, Sakamoto CC. The ability of the geriatric population to read labels on over-the-counter medication containers. J Am Optom Assoc 1994; 65 (1): 32-7
65. Wogalter MS, Magurno AB, Dietrich DA, et al. Enhancing information acquisition for over-the-counter medications by making better use of container surface space. Exp Aging Res 1999; 25 (1): 27-48
66. Lundberg L, Isacson D. The impact of over-the-counter availability of nasal sprays on sales, prescribing, and physician visits. Scand J Prim Health Care 1999; 17 (1): 41-5
67. Bodenheimer TS. Affordable prescriptions for the elderly. JAMA 2001; 286 (14): 1762-3
68. Martin RM, Quill J. Willingness to purchase over-the-counter (OTC) simvastatin 10mg is not related to coronary heart disease risk. BMJ 2005 [online]. Available from URL: http://bmj.bmjjournals.com/cgi/eletters/329/7461/ 310-e#76202 [Accessed 2005 Jan 26]
69. Bowden M, Benrimoj SI. Proposals for amending the criteria for transferring medicines from prescription to non-prescription. Aust Pharmacist 1994; 13: 519-25